Adverse Health Effects of Bisphenol A Adverse Health Effects of Bisphenol A ( BPA ) : Implications for the Use of BPA in Hemodialyzers and Other Medical Equipment Bisphenol
暂无分享,去创建一个
[1] A. Regenauer. Challenging Risk Assessment in Underwriting : Mental Disorders , 2012 .
[2] G. Prins,et al. Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk , 2012, Molecular and Cellular Endocrinology.
[3] J. Dötsch,et al. Fetal programming of renal function , 2012, Pediatric Nephrology.
[4] J. Muncke,et al. Endocrine disrupting chemicals and other substances of concern in food contact materials: An updated review of exposure, effect and risk assessment , 2011, The Journal of Steroid Biochemistry and Molecular Biology.
[5] S. Vandentorren,et al. Bisphenol-A and phthalates contamination of urine samples by catheters in the Elfe pilot study: implications for large-scale biomonitoring studies. , 2011, Environmental research.
[6] Paloma Alonso-Magdalena,et al. Endocrine disruptors in the etiology of type 2 diabetes mellitus , 2011, Nature Reviews Endocrinology.
[7] M. Shrubsole,et al. Renal Function, Bisphenol A, and Alkylphenols: Results from the National Health and Nutrition Examination Survey (NHANES 2003–2006) , 2010, Environmental health perspectives.
[8] Céline M. Laffont,et al. Similarity of Bisphenol A Pharmacokinetics in Rhesus Monkeys and Mice: Relevance for Human Exposure , 2010, Environmental health perspectives.
[9] C. Watson,et al. Nongenomic signaling pathways of estrogen toxicity. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[10] Laura N. Vandenberg,et al. Urinary, Circulating, and Tissue Biomonitoring Studies Indicate Widespread Exposure to Bisphenol A , 2010, Environmental health perspectives.
[11] John Peterson Myers,et al. A Clash of Old and New Scientific Concepts in Toxicity, with Important Implications for Public Health , 2009, Environmental health perspectives.
[12] L. Giudice,et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.
[13] S. Swan,et al. Bisphenol A Data in NHANES Suggest Longer than Expected Half-Life, Substantial Nonfood Exposure, or Both , 2009, Environmental health perspectives.
[14] Antonia M. Calafat,et al. Exposure to Bisphenol A and Other Phenols in Neonatal Intensive Care Unit Premature Infants , 2008, Environmental health perspectives.
[15] Koji Arizono,et al. Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A , 2008, Environmental health perspectives.
[16] E. Hugo,et al. Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. , 2008, The Journal of clinical endocrinology and metabolism.
[17] Andreas Kortenkamp,et al. Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. , 2008, International journal of andrology.
[18] Antonia M. Calafat,et al. Exposure of the U.S. Population to Bisphenol A and 4-tertiary-Octylphenol: 2003–2004 , 2007, Environmental health perspectives.
[19] Y. Kanno,et al. Effects of Endocrine Disrupting Substance on Estrogen Receptor Gene Transcription in Dialysis Patients , 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[20] C. Richter,et al. In vivo effects of bisphenol A in laboratory rodent studies. , 2007, Reproductive toxicology.
[21] S. Nakai,et al. Accumulation of Bisphenol A in Hemodialysis Patients , 2007, Blood Purification.
[22] Frederick S vom Saal,et al. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. , 2006, Endocrinology.
[23] B. Brenner,et al. Adult hypertension and kidney disease: the role of fetal programming. , 2006, Hypertension.
[24] Frederick S vom Saal,et al. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] Kristina A Thayer,et al. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. , 2003, Environmental health perspectives.
[26] H. Makino,et al. Determination of Bisphenol A in Effluents of Hemodialyzers , 2001, Nephron.
[27] K. Sugimura,et al. Endocrine-Disrupting Chemicals in CAPD Dialysate and Effluent , 2000, Blood Purification.
[28] S Z Cagen,et al. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[29] K A Thayer,et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[30] P. Christiansen,et al. Assessing chemical risk: societies offer expertise. , 2011, Science.
[31] J. Stockman,et al. Association of Urinary Bisphenol A Concentration With Medical Disorders and Laboratory Abnormalities in Adults , 2010 .
[32] Y. Haishima,et al. Elution of bisphenol-A from hemodialyzers consisting of polycarbonate and polysulfone resins. , 2001, Journal of biomedical materials research.
[33] E. Dodds,et al. Synthetic Œstrogenic Agents without the Phenanthrene Nucleus , 1936, Nature.
[34] C. Richter,et al. Journal of Steroid Biochemistry and Molecular Biology Estrogenic Environmental Chemicals and Drugs: Mechanisms for Effects on the Developing Male Urogenital System , 2022 .